Cargando…
HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media
Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035002/ https://www.ncbi.nlm.nih.gov/pubmed/29984222 http://dx.doi.org/10.3390/separations5010009 |
_version_ | 1783337976759058432 |
---|---|
author | Shah, Mansi Bourner, Luke Ali, Shariq Al-Enazy, Sanaalarab Youssef, Menatallah M. Fisler, Morgan Rytting, Erik |
author_facet | Shah, Mansi Bourner, Luke Ali, Shariq Al-Enazy, Sanaalarab Youssef, Menatallah M. Fisler, Morgan Rytting, Erik |
author_sort | Shah, Mansi |
collection | PubMed |
description | Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R(2) values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies. |
format | Online Article Text |
id | pubmed-6035002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60350022018-07-06 HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media Shah, Mansi Bourner, Luke Ali, Shariq Al-Enazy, Sanaalarab Youssef, Menatallah M. Fisler, Morgan Rytting, Erik Separations Article Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R(2) values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies. 2018-01-24 2018-03 /pmc/articles/PMC6035002/ /pubmed/29984222 http://dx.doi.org/10.3390/separations5010009 Text en http://creativecommons.org/licenses/by/4.0/ Submitted for possible open access publication under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shah, Mansi Bourner, Luke Ali, Shariq Al-Enazy, Sanaalarab Youssef, Menatallah M. Fisler, Morgan Rytting, Erik HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media |
title | HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media |
title_full | HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media |
title_fullStr | HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media |
title_full_unstemmed | HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media |
title_short | HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media |
title_sort | hplc method development for quantification of doxorubicin in cell culture and placental perfusion media |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035002/ https://www.ncbi.nlm.nih.gov/pubmed/29984222 http://dx.doi.org/10.3390/separations5010009 |
work_keys_str_mv | AT shahmansi hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia AT bournerluke hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia AT alishariq hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia AT alenazysanaalarab hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia AT youssefmenatallahm hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia AT fislermorgan hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia AT ryttingerik hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia |